Thyrocare Technologies Limited: SEBI Reg 74(5) Certificate for Q1FY27
Thyrocare Technologies Limited received a certificate for Q1FY27 under SEBI (Depositories and Participants) Regulations, 2018. Regulation 74(5) is not applicable as all shares are in demat form, and no rematerialization requests were received.
This is a standard regulatory filing confirming the dematerialized status of shares and absence of rematerialization requests, which is a routine process and has no material impact on the company's operations or financials.
The announcement is a routine compliance filing and does not contain any information that would positively or negatively impact the company's stock.
Thyrocare Technologies Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.
The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the Registrar and Share Transfer Agent.
According to the certificate, Regulation 74(5) is not applicable to Thyrocare Technologies Limited as the entire holding of the company's shares are in dematerialized form. Furthermore, no requests for rematerialization of shares were received from any shareholders during the quarter ended June 30, 2026.
What to do with a filing like this
Thyrocare Technologies Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Thyrocare Technologies Limited. Read the original for the full detail.